SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE

The medical condition or reason for a Sexual Health and HIV Episode.

National Codes:

 Diagnosis and/or treatment of infection or disease  
Code Description Definition/Guidance 
A1Primary syphilisThis refers to primary infectious syphilis. Laboratory confirmation is required.
A2Secondary syphilisThis refers to secondary infectious syphilis. Laboratory confirmation is required.
A3Early latent syphilisThis refers to patients who acquired syphilis in the preceding 2 years who have no signs of primary or secondary syphilis. Proof of negative serology within the preceding 2 years is required.
A4Cardiovascular syphilisThis refers to cardiovascular syphilis.
For codes A4-A5, the patient is only coded once in each of these categories in the United Kingdom, i.e. the patient is not given this code again unless there is a new complication. For example, a diagnosis of cardiovascular syphilis after having been diagnosed as a case of late latent syphilis.
Therefore patients attending for routine follow up of say, latent syphilis, are not re-coded in this category; and if they attend another clinic elsewhere in the country they are not coded as A4, A5, A6.
A5NeurosyphilisThis refers to syphilis of the nervous system.
For codes A4-A5, the patient is only coded once in each of these categories in the United Kingdom, i.e. the patient is not given this code again unless there is a new complication. For example, a diagnosis of cardiovascular syphilis after having been diagnosed as a case of late latent syphilis.
Therefore patients attending for routine follow up of say, latent syphilis, are not re-coded in this category; and if they attend another clinic elsewhere in the country they are not coded as A4, A5, A6.
A6All other late and latent syphilisThis refers to latent syphilis after the first two years of infection and all other latent syphilis.
For codes A4-A5, the patient is only coded once in each of these categories in the United Kingdom, i.e. the patient is not given this code again unless there is a new complication. For example, a diagnosis of cardiovascular syphilis after having been diagnosed as a case of late latent syphilis.
Therefore patients attending for routine follow up of say, latent syphilis, are not re-coded in this category; and if they attend another clinic elsewhere in the country they are not coded as A4, A5, A6.
A7 Congenital syphilis, aged under 2 years
(Retired 01 January 2011)
 
A8 Congenital syphilis, aged 2 years or over
(Retired 01 January 2011)
 
A9 Epidemiological treatment of suspected syphilis
(Retired 01 January 2011)
This should include all cases where syphilis has not been confirmed, but epidemiological treatment is prescribed because the index patient (the partner) was found to be syphilis positive. 
A7ACongenital syphilisSerological evidence of syphilis in an infant or child and clinical signs consistent with congenital syphilis, for example:
Early (<2 years): snuffles, skin and mucous membrane lesions, lymphadenopathy, hepatosplenomegaly.
Late (>2 years): gummatous ulcers, interstitial keratitis, optic atrophy, sensorineural deafness, Hutchinson’s incisors.
B1 Uncomplicated post-pubertal gonorrhoea
(Retired 01 January 2011)  
This includes all cases of uncomplicated gonorrhoea of the lower genitourinary tract, anorectum, mouth, throat, and adult conjunctivitis. Persistent/recurrent gonorrhoea:Treatment failures should not be given a new diagnosis. Patients who are thought to be re-infected should be regarded as new cases, and investigated, treated and diagnosed/coded accordingly. 
B2 Uncomplicated Pre-pubertal gonorrhoea
(Retired 01 January 2011) 
This includes all cases of uncomplicated gonorrhoea of the lower genitourinary tract, anorectum, mouth, throat, and adult conjunctivitis. Persistent/recurrent gonorrhoea:Treatment failures should not be given a new diagnosis, Patients who are thought to be re-infected should be regarded as new cases, and investigated, treated and diagnosed/coded accordingly. 
B3 Gonococcal ophthalmia neonatorum
(Retired 01 January 2011)
 
B4 Epidemiological treatment of suspected gonorrhoea
(Retired 01 January 2011)
This should include all cases where gonorrhoea has not been confirmed, but where epidemiological treatment has been prescribed because the index patient (the partner) was found to be infected with gonorrhoea.
B5 Complicated gonococcal infection - including pelvic inflammatory disease and epididymitis
Retired 01 January 2011)
This includes all cases of complicated gonorrhoea e.g. upper genitourinary tract complications (such as pelvic inflammatory disease and epididymitis), and systemic complications. Where a patient has complications that are associated with both gonococcal and chlamydial infections, the patient should be included as B5 and as C4B. 
BGonorrhoeaThis includes all cases of complicated and uncomplicated gonorrhoea (pre- and post-pubertal) involving any site.
Persistent/recurrent gonorrhoea:
Treatment failures should not be given a new diagnosis.  Treatment failures include those in whom first line antibiotics have failed (for example, symptoms not resolved, antibiotics not taken correctly) and those who have had sexual intercourse with an untreated partner (not a new partner) within 6 weeks.
Patients who are thought to be newly infected after a previous episode of gonorrhoea should be regarded as a new GUM episode and be investigated, treated and diagnosed/coded accordingly.  
C1ChancroidLaboratory confirmation is essential for this condition.
C2Lymphogranuloma venereumLaboratory confirmation is essential for this condition.
C3DonovanosisLaboratory confirmation is essential for this condition.
C4A Uncomplicated chlamydial infection of the lower genital tract
(Retired 01 January 2011)
This includes all cases of uncomplicated chlamydial infections (diagnosed by culture or antigen detection) involving the lower genitourinary tract. Persistent/recurrent chlamydia:Treatment failures should not be given a new diagnosis. Patients who are thought to be re-infected should be regarded as new cases, and investigated, treated and diagnosed/coded accordingly. 
C4B Complicated chlamydial infection - including pelvic inflammatory disease and epididymitis
(Retired 01 January 2011)
This includes all cases of complicated chlamydial infections e.g. upper genitourinary tract complications (such as pelvic inflammatory disease and epididymitis), perihepatitis and arthritis. Diagnosis may be based on culture, antigen detection or high micro-immunoflourescence titre. Where a patient has complications that are associated with both gonococcal and chlamydial infections, the patient should be included as B5 and as C4B. 
C4C Uncomplicated chlamydial infection, other sites
(Retired 01 January 2011)
This includes all cases of uncomplicated chlamydial infections (diagnosed by culture or antigen detection) involving all other sites and including adult conjunctivitis. Persistent/recurrent chlamydia:Treatment failures should not be given a new diagnosis. Patients who are thought to be re-infected should be regarded as new cases, and investigated, treated and diagnosed/coded accordingly.This includes all cases of complicated chlamydial infections e.g. upper genitourinary tract complications (such as pelvic inflammatory disease and epididymitis), perihepatitis and arthritis. Diagnosis may be based on culture, antigen detection or high micro-immunoflourescence titre. Where a patient has complications that are associated with both gonococcal and chlamydial infections, the patient should be included as B5 and as C4B. 
C4D Chlamydial ophthalmia neonatorum
(Retired 01 January 2011)
 
C4E Epidemiological treatment of suspected chlamydia
(Retired 01 January 2011)
This should include all cases where chlamydia has not been confirmed, but where epidemiological treatment has been prescribed because the index patient (the partner) was found to be chlamydia positive. If a male partner presents as a contact of C4A and has non-specific urethritis, he should be coded as C4H only and not C4E. 
C4H Uncomplicated non-gonococcal/non-specific urethritis in males, or treatment of mucopurulent cervicitis in females
(Retired 01 January 2011)
In males, this is diagnosed in the absence of gonorrhoea and laboratory confirmed chlamydia and the presence of polymorphonuclear leucocytes at >5 per high power field. Also, if a male partner presents as a contact of C4A and has non-specific urethritis, he should be coded as C4H only and not C4E. Females being treated for non-specific mucopurulent cervicitis are also to be coded C4H.Persistent/recurrent urethritis:Treatment failures should not be given a new diagnosis. Patients who are thought to be re-infected should be regarded as new cases, and investigated, treated and diagnosed/coded accordingly. 
C4I Epidemiological treatment of non-specific genital infection
(Retired 01 January 2011)
This diagnosis is used for either males or females; e.g. the female would be diagnosed as C4I if she tested negative for gonorrhoea and chlamydia and is treated because her partner had been diagnosed with uncomplicated or complicated non-specific infection (C4H or C5). Similarly, the male partner is diagnosed as C4I if he tested negative for gonorrhoea and chlamydia and is treated because the female partner has been diagnosed as C4H or C5. 
C4Chlamydial infectionThis includes all cases of complicated and uncomplicated Chlamydia trachomatis  infections (diagnosed by culture or antigen detection) involving any site.
Persistent/recurrent chlamydia:
Treatment failures should not be given a new diagnosis.  Treatment failures include those in whom first line antibiotics have failed (for example, symptoms not resolved, antibiotics not taken correctly) and those who have had sexual intercourse with an untreated partner (not a new partner) within 6 weeks.
Patients who are thought to be newly infected after a previous episode of chlamydia should be regarded as a new GUM episode and be investigated, treated and diagnosed/coded accordingly.
C4NNon-specific genital infectionThis includes all cases of complicated and uncomplicated NSGI.
In males, this is diagnosed in the absence of gonorrhoea and laboratory confirmed chlamydia and the presence of polymorphonuclear leucocytes at >5 per high power field.
Females being treated for non-specific mucopurulent cervicitis are also to be coded C4N.
Persistent/recurrent urethritis:
Treatment failures should not be given a new diagnosis.  Treatment failures include those in whom first line antibiotics have failed (for example, symptoms not resolved, antibiotics not taken correctly) and those who have had sexual intercourse with an untreated partner (not a new partner) within 6 weeks.
Patients who are thought to be newly infected after a previous episode of non-specific infection should be regarded as a new GUM episode and be investigated, treated and diagnosed/coded accordingly. 
C5 Complicated infection (non-chlamydial/non-gonococcal) - including pelvic inflammatory disease and epididymitis
(Retired 01 January 2011)
This includes all cases of complicated non-specific infections requiring treatment and negative tests for gonorrhoea and chlamydia e.g. upper genitourinary tract complications (such as pelvic inflammatory disease and epididymitis), prostatitis and arthritis. 
C5APelvic inflammatory disease and epididymitisThis includes all cases of pelvic inflammatory disease and all cases of epididymitis associated with chlamydial, gonococcal or non-specific infections. Can be used with the relevant infection code, where appropriate. Other complications should be coded D2B.
C5BOphthalmia neonatorumThis includes all cases of ophthalmia neonatorum. Can be used with the relevant infection code.
C6ATrichomoniasisIf associated with bacterial vaginosis then code C6A only should be used.
C6BAnaerobic/Bacterial vaginosis and anaerobic balanitisDiagnosis of bacterial vaginosis is generally based on microscopy, pH vaginal fluid and the amine test. This diagnosis is very rarely appropriate in males and used only if the patient has confirmed anaerobic balanitis. Other and non-confirmed anaerobic balanitis should be coded as C6C. Asymptomatic patients who do not require treatment should not be coded C6B.
C6COther vaginosis/vaginitis/ balanitis 
C7A Anogenital candidosis
(Retired 01 January 2011)
This is diagnosed only when there is microscopic or culture evidence of Candida infection. Asymptomatic patients who do not require treatment should not be coded C7A. 
C7B Epidemiological treatment of C6 and C7
(Retired 01 January 2011)
This should include all cases where C6 and C7 have not been confirmed, but where epidemiological treatment has been prescribed. 
C7Anogenital candidosisThis is diagnosed only when there is microscopic or culture evidence of Candida infection.  If no microbiological evidence then case should be coded as C6C.  Asymptomatic patients who do not require treatment should be coded D3.
C8ScabiesThis includes cases treated on either a clinical or epidemiological basis. Treatment failures should not be given a new diagnosis. Patients who are thought to be re-infected should be regarded as new cases, and investigated, treated and diagnosed/coded accordingly.
C9Pediculosis pubisThis includes cases treated on either a clinical or epidemiological basis. Treatment failures should not be given a new diagnosis. Patients who are thought to be re-infected should be regarded as new cases, and investigated, treated and diagnosed/coded accordingly.
C10AAnogenital Herpes simplex: first episodeAn episode should be recorded here only if the patient has never (as far as can be ascertained) previously had a confirmed diagnosis with anogenital herpes at any Genitourinary Medicine clinic. Laboratory confirmation is essential.
C10BAnogenital Herpes simplex: recurrenceThis should include all other episodes of anogenital herpes. If there has been previous confirmation, then clinical judgement is enough for this diagnosis.
C11AAnogenital warts infection: first episodeAn episode should be recorded here only if the patient has never (as far as can be ascertained) been previously treated for anogenital warts at any Genitourinary Medicine clinic.
C11A diagnosis refers to macroscopic warts, not acetowhite patches or abnormalities revealed by acetowhite staining, nor is the cytological finding of wart virus change sufficient to use this code.
C11B Anogenital warts infection: recurrence
(Retired 01 January 2011)  
This should include patients in whom warts reappeared after a wart-free interval of at least 3 months. C11B diagnosis refers to macroscopic warts, not acetowhite patches or abnormalities revealed by acetowhite staining, nor is the cytological finding of wart virus change sufficient to use this code. 
C11C Anogenital warts: Re-registered cases
(Retired 01 January 2011)  
This is to be used for a patient previously diagnosed as C11A or C11B in whom warts persist and treatment continues for longer than three months, or which recur within 3 months of apparent eradication. This code is not to be re-entered for the same patient more than once every 3 months.C11C diagnosis refers to macroscopic warts, not acetowhite patches or abnormalities revealed by acetowhite staining, nor is the cytological finding of wart virus change sufficient to use this code. 
C11DAnogenital warts infection: recurrenceThis should include all other episodes of anogenital warts and should only be used once per episode.
C11D diagnosis refers to macroscopic warts, not acetowhite patches or abnormalities revealed by acetowhite staining, nor is the cytological finding of wart virus change sufficient to use this code. 
C12Molluscum contagiosum 
C13A Viral hepatitis B: Hepatitis B surface antigen (HbsAg) positive: First diagnosis
(Retired 01 January 2011)
C13A records a first diagnosis of antigen positive hepatitis B. 
C13B Viral hepatitis B: Hepatitis B surface antigen (HbsAg) positive: Acute viral hepatitis B at first diagnosis
(Retired 01 January 2011)  
C13B is a subset of C13A, so that a patient coded C13B must also be coded C13A. C13B records the number of first diagnoses of hepatitis B infections that were acute, where this is known. The definition of acute hepatitis B is newly identified HBsAg positive with Hepatitis B core antigen (anti-HBc) Immunoglobulin M (IgM) positive (>200 iu/l) or discrete onset of jaundice or anicteric illness accompanied by deranged Liver function tests (LFTs) (Aspartate aminotransferase (AST) / Alanine aminotransferase (ALT) >2x normal range) accompanied by HBsAg and Hepatitis B core antigen (anti-HBc) Immunoglobulin M (IgM) positive. 
C13C Viral hepatitis B: subsequent presentation
(Retired 01 January 2011)  
All subsequent presentations of hepatitis B that require management, or known carriers of hepatitis B who present at a clinic for the first time, should be coded as C13C. Subsequent attendances by carriers that are unrelated to hepatitis B management should not be coded as C13C. 
C13Viral hepatitis B (HbsAg positive): First diagnosisC13 records a first diagnosis of antigen positive hepatitis B. Known carriers of hepatitis B who present at a clinic for the first time should also be coded as C13.
All subsequent presentations of hepatitis B that require management should be coded as D2B. Subsequent attendances by carriers that are unrelated to hepatitis B management should not be coded. 
C14Viral hepatitis C: first diagnosisThis code records the first diagnosis of hepatitis C, defined as anti-HCV positive or Hepatitis C virus (HCV) Ribonucleic acid (RNA) positive. All other hepatitis diagnoses should be coded as D2B/D3.
C15Viral hepatitis A: acute infectionThis code records a diagnosis of acute hepatitis A, defined as detection of hepatitis A virus specific IgM antibodies.
D2AUrinary Tract InfectionIncludes all patients with a positive culture, otherwise patients should be coded D2B. 
D2BOther conditions requiring treatment at GUM clinic 
E1A New Human Immunodeficiency Virus (HIV) diagnosis: asymptomatic
(Retired 01 January 2011)  
This is a new HIV diagnosis in a patient without symptoms who is not known to have been diagnosed previously at any Genitourinary Medicine clinic. It includes patients with seroconversion illness. A patient can receive this code only once and it is mutually exclusive of E2A and E3A1. 
E2A New Human Immunodeficiency Virus (HIV) diagnosis: symptomatic (not AIDS)
(Retired 01 January 2011)
This is a new HIV diagnosis in a patient with symptoms who is not known to have been diagnosed previously at any Genitourinary Medicine clinic. It excludes patients with seroconversion illness (see code E1A). A patient can receive E2A only once and it is mutually exclusive of E1A and E3A1. 
E1B Subsequent asymptomatic Human Immunodeficiency Virus (HIV) presentation (not AIDS)
(Retired 01 January 2011)
Includes all subsequent presentations by an asymptomatic patient who has been diagnosed with HIV previously (and therefore excludes those with AIDS). The patient should be given this code only once during any quarterly period. 
E2B Subsequent symptomatic Human Immunodeficiency Virus (HIV) presentation (not AIDS)
(Retired 01 January 2011)
Includes all subsequent presentations by a symptomatic patient who has been diagnosed with HIV previously, but excludes those with AIDS. The patient should be given this code only once during any quarterly period. 
E3A1 AIDS: first presentation - new Human Immunodeficiency Virus (HIV) diagnosis
(Retired 01 January 2011)
An AIDS diagnosis is used for HIV infected patients with one or more AIDS indicator diseases. It is necessary to discriminate between first AIDS presentations that are also the first HIV diagnosis and those for which HIV was diagnosed previously. E3A1 is a first presentation of AIDS where HIV has not been diagnosed previously. The patient (as far as can be ascertained) should not have been given an HIV or AIDS diagnosis at any clinic in the United Kingdom. This patient cannot be coded E1 or E2 ever again. E3A1 is mutually exclusive of E3A2. 
E3A2 AIDS: first presentation - Human Immunodeficiency Virus (HIV) diagnosed previously
(Retired 01 January 2011)
E3A2 is a first presentation of AIDS where HIV has been diagnosed previously. The patient (as far as can be ascertained) should not have been given an AIDS diagnoses at any clinic in the United Kingdom. This patient cannot be coded E1 or E2 ever again. E3A2 is mutually exclusive of E3A1. 
E3B AIDS: subsequent presentation
(Retired 01 January 2011)
The patient who has had an AIDS diagnosis at any time in the past should be given this code only once during any quarterly period and cannot be coded E1, E2 or E3A ever again. 
HHIV positiveThis code is to be use for first attendances in patients who are known to have previously been diagnosed with HIV infection in any clinical setting but who are not attending specifically for HIV-related care. 
Codes H, H1, H1A, H1B and H2 are all mutually exclusive. 
H1New HIV diagnosisThis includes all new HIV diagnoses. Codes H, H1, H1A, H1B and H2 are all mutually exclusive.
H1ANew HIV diagnosis: AcuteThis includes all new HIV diagnoses which have evidence of one or more of the following in the last 6 months:
a) a documented negative HIV test
b) laboratory evidence (e.g. RITA assay, RNA, neutralisable p24 antigen and antibody negative), or
c) evidence of seroconversion illness.
Codes H, H1, H1A, H1B and H2 are all mutually exclusive.
H1BNew HIV diagnosis: LateThis includes all new HIV diagnoses which have a clinical AIDS diagnosis within three months of their HIV diagnosis.
Codes H, H1, H1A, H1B and H2 are all mutually exclusive.
H2Attendance for HIV-related careThis includes all attendances relating to HIV care.
Codes H, H1, H1A, H1B and H2 are all mutually exclusive.
P4ACervical cytology: minor abnormalityIncludes smears showing lower grades (i.e. borderline or mild) of dyskaryosis on cytological examination.
P4BCervical cytology: major abnormalityIncludes smears showing moderate or worse (i.e. moderate or severe) dyskaryosis on cytological examination.
 Services Provided
The services provided codes are used to code patients receiving services or undergoing tests.  
S1 Sexual health screen (no Human Immunodeficiency Virus (HIV) antibody test)
(Retired 01 January 2011)
S1 should only be used where a full sexual health screen is given (i.e. including gonorrhoea and chlamydia testing) and should not be used to record tests for recurrent candidosis/ bacterial vaginosis etc. It will be used to count all patients who are given a sexual health screen excluding an HIV test. (This may be because the patient refuses or is not offered an HIV test. However, if the patient is known to be HIV antibody positive, he/she can be coded S1 and one of E1B/E2B/E3A2/E3B). S1 is mutually exclusive of S2 and P1A. 
S2 Human Immunodeficiency Virus (HIV) antibody test and sexual health screen
(Retired 01 January 2011)  
S2 is used to count all patients who are given a sexual health screen including an HIV test. It should only be used where a full sexual health screen is given (i.e. including gonorrhoea and chlamydia testing) and should not be used to record tests for recurrent candidosis/ bacterial vaginosis etc. If the patient tests positive for HIV antibody then they would be coded S2, E1A. S2 is mutually exclusive of S1, P1A and P1B. 
T1Chlamydia testT1 should be used for patients tested for chlamydia but who are not tested for gonorrhoea or syphilis.
T1 is mutually exclusive of T2, T3 and T4 but may be used with P1A, P1B and P1C. 
T2Chlamydia and gonorrhoea testsT2 should be used to code a sexual health screen which includes gonorrhoea and chlamydia testing but excludes syphilis testing.
T2 is mutually exclusive of T1, T3 and T4 but may be used with P1A, P1B and P1C. 
T3Chlamydia, gonorrhoea and syphilis testsT3 should only be used to code a sexual health screen which includes gonorrhoea, chlamydia and syphilis testing but excludes HIV testing.
T3 is mutually exclusive of T1, T2, T4 and P1A but may be used with P1B and P1C.  
T4Full sexual health screen including HIV antibody testT4 is used to code a full sexual health screen including gonorrhoea, chlamydia, syphilis and HIV testing.
T4 is mutually exclusive of T1, T2, T3, P1A, P1B and P1C.  
P1AHuman Immunodeficiency Virus (HIV) antibody test (no sexual health screen)This code is to be used for any HIV antibody testing done which is not part of a full sexual health screen as described by code T4. 
P1A is mutually exclusive of T3, T4, P1B and P1C but may be used with T1 and T2.
P1BHuman Immunodeficiency Virus (HIV) antibody test offered and refusedThis code refers to all patients offered an HIV test who decline the test even though the clinician believes there is some possible HIV risk that could be screened by testing on that day.  The code is used regardless of whether a pre-test discussion or counselling was given, or whether the patient intends to test in the future.
P1B is mutually exclusive of T4, P1A and P1C.
P1CHIV test inappropriateThis code is used to describe a patient attendance where an HIV test was not offered because it was not appropriate or was offered but after discussion it was deemed not appropriate e.g. where the patient has been recently tested, is in the ‘window’ period, is already known to be HIV positive etc.
P2 Hepatitis B vaccination (1st dose only)
(Retired 01 January 2011)  
Only the 1st dose of any new Hepatitis B vaccination course should be included. This would include those patients who may have been vaccinated some time in the past but are now receiving the first dose of a new course of vaccination. Subsequent doses and boosters should be coded as D2B. 
P2AHepatitis B vaccination: 1st doseOnly the 1st dose of any new Hepatitis B vaccination course should be included. This would include those patients who may have been vaccinated some time in the past but are now receiving the first dose of a new course of vaccination. Subsequent doses should be coded P2B/P2C and boosters should be coded as D2B.
P2BHepatitis B vaccination: 2nd doseIncludes only the second dose of a Hepatitis B vaccination course, including those who are known to have received a first dose at another clinic.
P2CHepatitis B vaccination: 3rd doseIncludes only the third dose of a Hepatitis B vaccination course, including those who are known to have received a first and/or second dose at another clinic.
P2IHepatitis B immuneIncludes patients who are ineligible for hepatitis B vaccination because they are already immune. This should only be recorded once, the first time a patient attends a particular clinic, or when first known to be immune.
P3Contraception (excluding condom provision)This code will be used to record contraception (females only), including prescribing and sexual and reproductive health advice, and excluding condom provision.
P4Cervical cytology doneIncludes all patients who had cervical cytology done, regardless of outcome.
W1HPV vaccination: 1st doseOnly the 1st dose of any new human papillomavirus vaccination course should be included. This would include those patients who may have been vaccinated some time in the past but are now receiving the first dose of a new course of vaccination. Subsequent doses should be coded W1/2.
W2HPV vaccination: 2nd doseIncludes only the second dose of a HPV vaccination course, including those who are known to have received a first dose at another clinic.
W3HPV vaccination: 3rd doseIncludes only the third dose of a HPV vaccination course, including those who are known to have received a first and/or second dose at another clinic.
PNPartner notification initiatedLevel 2 & Level 1 services only: Partner notification has been initiated for this patient by this clinic.
PNCPartner notification: ChlamydiaThis should be used for those presenting as a partner of an index case diagnosed with chlamydia (at this or any setting). If the partner is found to be infected with chlamydia he/she should also be coded C4.
PNGPartner notification: GonorrhoeaThis should be used for those presenting as a partner of an index case diagnosed with gonorrhoea (at this or any setting). If the partner is found to be infected with gonorrhoea he/she should also be coded B.
PNSPartner notification:
Syphilis  
This should be used for those presenting as a partner of an index case diagnosed with syphilis (at this or any setting). If the partner is found to be infected with syphilis he/she should also be coded A1, A2 or A3.
PNHPartner notification: HIVThis should be used for those presenting as a partner of an index case diagnosed with HIV (at this or any setting). If the partner is found to be infected with HIV he/she should also be coded H1, H1A or H1B.
PEPSPost exposure prophylaxis after sexual exposure (PEPSE)Used for patients given HIV prophylaxis following sexual exposure
D3Other episodes not requiring treatmentD3 is used to code any new patient episode where no treatment is given, whether or not a sexual health screen and/or an HIV test are/is performed. D3 can therefore be used to record an episode where a patient tests negative for all tests done, or where testing the patient is not indicated and otherwise no treatment is given.
D3 may also be used to record any other contact with a patient for clinical purposes but which does not result in treatment. Patients who do not attend appointments may be coded D3 if a) they have already been triaged, or b) they have had contact with a health advisor. Otherwise patients who do not attend should not be coded D3.
D3 can be used only once per patient episode.
 Special Patient Groups
It is useful to record additional information on certain patient groups receiving services or undergoing tests. Codes to be reported separately at each First Attendance.  
ZPrisonerThe ‘Z’ code is used to code the provision of a service to a patient known to be a current prisoner.
SWSex WorkerThe ‘SW’ code is used to code the provision of a service to a patient known to be a current sex worker.
 Suffixes to Codes
For a number of conditions it is useful to record additional information about the patient’s presentation or service given. This information may be collected through the use of suffixes which can be applied to some Sexual Health and HIV Activity Property codes. Where appropriate, multiple suffixes can be used on the same Sexual Health and HIV Activity Property code. The suffixes and the codes with which they can be used are given below. These codes are appended to the Sexual Health and HIV Activity Property Code.  
RRectal infectionThe ‘R’ suffix is added where a diagnosis includes infection of the anorectum. Where the patient is infected at multiple sites including the anorectum the patient need only be coded once using the Sexual Health and HIV code and the ‘R’ suffix.
Suffix code may be used with B, C4, C2, C4N
OPharyngeal infectionThe ‘O’ suffix is added where a diagnosis includes a pharyngeal infection but excludes anorectal and genital infections.
Suffix code may be used with B, C4, C2
XDiagnosed previously elsewhereFor use in GUM only: The ‘X’ suffix is added where a patient is known to have been diagnosed with their presenting condition at another non-GUM clinic health setting in the UK before this attendance.
Suffix code may be used with B, C4, H1, H1A, H1B
MMedication givenFor use in Level 2 & level 1 services only: The patient was given/prescribed treatment at this setting for the presenting condition. The M suffix should be used whether or not the patient is then referred for further management.
Suffix code may used with B, C4, C10A, C10B, C11A, C11D.
QQuadrivalent HPV vaccineThe ‘Q’ suffix is added where a patient being immunised against HPV receives the quadrivalent vaccine.
Suffix code may be used with W1, W2, W3  
 Permissible Code Permutations Using Suffixes  
 B - Gonorrhoea 
BRRectal infection 
BOPharayngeal infection 
BXDiagnosed previously elsewhere 
BMMedication given 
BRXRectal infection, Diagnosed previously elsewhere 
BRMRectal infection, Medication given  
BOXPharayngeal infection, Diagnosed previously elsewhere  
BOMPharayngeal infection, Medication given  
 C4 - Chlamydia 
C4RRectal infection 
C4OPharayngeal infection  
C4XDiagnosed previously elsewhere  
C4MMedication given  
C4RXRectal infection, Diagnosed previously elsewhere  
C4RMRectal infection, Medication given  
C4OXRectal infection, Diagnosed previously elsewhere  
C4OMRectal infection, Medication given  
 C2 - LGV 
C2RRectal infection  
C2OPharayngeal infection  
 C4N - NSGI 
C4NRProctitis 
 H1 - HIV 
H1XDiagnosed previously elsewhere  
 H1A - HIV 
H1AXDiagnosed previously elsewhere  
 H1B - HIV 
H1BXDiagnosed previously elsewhere  
 C10A - HSV 
C10AMMedication given 
 C10B - HSV 
C10BMMedication given  
 C11A - Warts 
C11AMMedication given  
 C11D - Warts 
C11DMMedication given  
 W1 - HPV Vaccine 
W1QQuadrivalent Vaccine 
 W2 - HPV Vaccine 
W2QQuadrivalent Vaccine  
 W3 - HPV Vaccine 
W3QQuadrivalent Vaccine  

The National Code mapping list to KC60 has been retired from the NHS Data Model and Dictionary as at 01 April 2010 due to the retirement of KC60 which has been replaced by the Genitourinary Medicine Clinic Activity Data Set.

The last live version of KC60 is available in the May 2010 release of the NHS Data Model and Dictionary.

Access to this version can be obtained by emailing information.standards@hscic.gov.uk with "NHS Data Model and Dictionary - Archive Request" in the email subject line.

 

This attribute is also known by these names:
ContextAlias
formerlyGENITOURINARY EPISODE TYPE
pluralSEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPES